A randomised, placebo-controlled, dose-rising study in healthy males volunteers to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of SVT-40776, a novel selective M3 antimuscarinic
Viayna C1, Alvarez D 1, López R1, Sanagustín J1, Lagunas C1 1. Laboratorios SALVAT, S.A
| Abstract 270 |
| Non Discussion Posters: Scientific Non Discussion Poster Session 19 |
|